Delirium: an emerging frontier in the management of critically ill children

Heidi A B Smith1, D Catherine Fuchs, Pratik P Pandharipande

  • 1Department of Anesthesiology, Vanderbilt University School of Medicine, Nashville, TN 37232, USA. heidi.smith@vanderbilt.edu

Anesthesiology Clinics
|November 15, 2011
PubMed

Insights

Pediatric delirium, a common brain dysfunction in critically ill children, lacked diagnostic tools. A new pediatric tool, the pCAM-ICU, enables better study and management of this condition.

Area of Science:

  • Pediatric Critical Care Medicine
  • Neuroscience
  • Intensive Care Medicine

Background:

  • Delirium, a syndrome of acute brain dysfunction, is prevalent in critically ill children globally.
  • Lack of validated bedside diagnostic tools has hindered understanding of pediatric delirium's incidence, prevalence, and severity.
  • In adults, delirium significantly increases morbidity and mortality in intensive care settings.

Purpose of the Study:

  • To address the diagnostic gap for pediatric delirium.
  • To introduce and describe the pediatric Confusion Assessment Method for the Intensive Care Unit (pCAM-ICU) tool.
  • To highlight the importance of studying pediatric delirium for improved clinical management and research.

Main Methods:

  • Review of emerging solutions for pediatric delirium diagnosis.
  • Description of the development and features of the pCAM-ICU tool.
  • Discussion of the implications of validated diagnostic tools in pediatric critical care.

Main Results:

  • The pCAM-ICU is presented as a novel, validated instrument for routine bedside diagnosis of delirium in critically ill children.
  • The availability of such tools facilitates the study of pediatric delirium epidemiology.
  • The introduction of pCAM-ICU enables the development and testing of clinical management algorithms.

Conclusions:

  • Validated tools like pCAM-ICU are essential for advancing the understanding and management of pediatric delirium.
  • Accurate diagnosis will allow for the incorporation of delirium as a critical outcome measure in pediatric critical care research.
  • Improved study of pediatric delirium will lead to better clinical outcomes for critically ill children.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Acute Kidney Injury VI: Nursing Management01:22

Acute Kidney Injury VI: Nursing Management

Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...